Pharmaceutical Technology

MAY 30, 2023

According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. These drugs are set to make a combined $4.34bn in sales in 2028. Similarly, Almirall S.A.,

Sales 105

Sales Marketing Prescription Pharma 105

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 93

Medicine Healthcare Healthcare Pharma 93

Pharma Marketing Network

OCTOBER 26, 2022

Join Reuters Events’ exclusive panel discussion to hear experts from Novartis, Takeda and Janssen share business-critical learnings, including: Differentiate predictive vs prescriptive insights and inform your next best action. The post Pharma USA 2023 | March 28–29, 2023 appeared first on Pharma Marketing Network.

Pharma 52

Pharma Prescription Marketing Networking 52

PharmExec

NOVEMBER 7, 2023

Exagamglogene autotemcel (Exa-Cel) was assigned a Prescription Drug User Fee Act action date of December 8, 2023, for the treatment of sickle cell disease.

Prescription 98

Prescription Pharmaceutical 98

PM360

SEPTEMBER 21, 2023

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.

Management 105

Management Manufacturing Sales Competition 105

pharmaphorum

DECEMBER 23, 2022

And in 2023, these investments will hopefully pay off. In 2023, omnichannel behaviours will directly influence incentive compensation models by correlating successful engagement data to successful sales outcomes. Food and Drug Administration’s Office of Prescription Drug Promotion ( OPDP ).”.

Marketing 96

Marketing Sales Medical Patients 96

MedCity News

OCTOBER 9, 2023

The opening day of the HLTH 2023 event offered a surprising announcement from venture capital firm General Catalyst. ENGAGE at HLTH offered compelling discussions around retail health, prescription drug prices and investment trends. Weight Watchers CEO called for a change in how we talk about obesity.

Retail 102

Retail Prescription 102

MedCity News

MARCH 14, 2023

CMS Administrator Chiquita Brooks-LaSure discussed CMS’ key focus areas for 2023. This includes the end of the public health emergency, health equity and prescription drug costs. During an interview at the AHIP Medicare, Medicaid, Duals and Commercial Markets Forum held Tuesday in Washington, D.C.,

Prescription 90

Prescription Marketing 90

PM360

MAY 15, 2023

She combines business problem-solving with a tremendously human-centered approach to their desired outcomes, examining a brand’s specific ability to impact access and speed along the patient prescription journey.” Laura is not shy about sharing her cancer experience.

Sales 94

Sales Pharma sales reps Prescription Recruitment 94

pharmaphorum

DECEMBER 22, 2022

As this collective body of experience continues to proliferate, 2023 will see additional FDA guidance. In 2023, expect to see AI innovations improve enrolment agility and, most importantly, the patient experience in a clinical trial. Beyond 2023 – the Sovereign Patient ID.

FDA 85

FDA Patients Electronics Medical 85

pharmaphorum

JANUARY 27, 2023

It’s wise advice from the “Sage of Omaha”; indeed, one highly respected financial newspaper began its 2023 predictions by conceding that it had been wrong on five major counts for 2022. Demand has also increased due to changes in prescribing protocols, leading to a higher underlying number of prescriptions for certain antibiotic medicines.

Medicine 91

Medicine Government Marketing Transportation 91

PharmExec

APRIL 14, 2023

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Pharma 52

Pharma Prescription Leads Patients 52

Nixon Gwilt Law

FEBRUARY 27, 2023

Late Friday (February 24, 2023), the US Drug Enforcement Agency (DEA) released a proposed rule to make permanent some of the flexibilities allowed during the Public Health Emergency (PHE) for telemedicine companies whose providers prescribe controlled substances. Now let’s get to it.

Prescription 105

Prescription Medical Patients Specialization 105

MedCity News

MARCH 7, 2023

WeightWatchers will acquire Sequence, a platform that allows patients to have virtual appointments with a clinician, gives access to a dietitian and fitness coaching and provides prescription medications, including Ozempic and Wegovy.

Management 91

Management Prescription Medical Patients 91

PM360

DECEMBER 14, 2023

Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications.

Medical 105

Medical Side effects Physicians Prescription 105

Pharmaceutical Commerce

NOVEMBER 10, 2023

Blue Fin Group exec speaks on his upcoming feature.

Prescription 52

Prescription 52

Eversana Intouch

JANUARY 19, 2023

Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. Pharma marketers in 2023 need to: Look for blind spots. Each year, we forecast several trends that will influence life-sciences marketing the most in the months to come ahead.

Medical 52

Medical Education Competition Marketing 52

MedReps

JANUARY 30, 2023

Medical Sales Trends to Watch Out For in 2023 If you want to know what the future holds and create some forward-thinking sales goals, then check out these medical sales trends to watch out for in 2023. Along with an increase in elderly people, there’s also more healthcare spending taking place.

Medical sales 74

Medical sales Medical Sales Sales goal 74

PM360

JULY 13, 2023

What if the industry were to incentivize persistence over new prescriptions? NRx data drives stock prices, determines ROI, and directs bonuses. What if instead of short-term gains, we prioritized the long game? Imagine if we collectively proclaimed that the real value is not only in starting, but in staying.

Patients 98

Patients Medical Education Transportation 98

PM360

OCTOBER 13, 2023

It seems fewer doctors guide patients to intermittent fasting (62%) or anaerobic exercise (55%) than to prescription weight loss drugs and aerobic exercise. InCrowd also uncovered some other surprising doctor perceptions.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

PM360

MAY 15, 2023

Karina joined OptimizeRx in 2021, where she has increased the digitalization of access to help move drug manufacturers away from manual processes.

Physicians 59

Physicians Electronics Prescription Manufacturing 59

PM360

APRIL 7, 2023

This is especially significant for manufacturers of high-cost specialty drugs, who will now face a recurring additional 20% charge on virtually every prescription fill. On the other side, drug manufacturers are facing the squeeze, with caps on price inflation and a mandated 20% discount in the catastrophic phase.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

MedCity News

FEBRUARY 4, 2024

In 2023, prescription drug costs rose by 8.4%, a 31% increase from the prior year. By enforcing transparency, PBMs would need to release detailed information on prescription drug spending. 2024 stands at a critical juncture in the battle against soaring pharmacy costs. Transparency and reporting requirements.

Prescription 94

Prescription Networking Management Pharmaceutical 94

Pharmacy Times

AUGUST 18, 2023

Based on results from a trial of repotrectinib in patients with ROS1-positive locally advanced or metastatic non-small cell lung cancer, the FDA accepted the New Drug Application and set a Prescription Drug User Fee Act goal date of November 27, 2023.

Prescription 48

Prescription FDA Patients 48

World of DTC Marketing

MARCH 10, 2022

The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. The increase followed total Humira price hikes of 19 percent during 2017 and 2018. The executives at AbbVie make over $300 million.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Manufacturing 205

European Pharmaceutical Review

OCTOBER 24, 2023

Contributing factors include greater demand for prescription drugs , advancements in the designing and printing of labels, high investments as well as pharmaceutical sales, plus high research and development (R&D) expenditures on pharmaceuticals and government initiatives. percent between the forecast period: 2023 and 2028.

Pharmaceutical 98

Pharmaceutical Marketing Medicine Pharmaceutical Sales 98

Pharmaceutical Technology

JUNE 21, 2023

The company expects to launch LODOCO for prescription use in the second half of 2023. “We are dedicated to addressing heart disease, the leading cause of death, by ensuring all patients have access to LODOCO.”

Food and Drug Administration 98

Food and Drug Administration FDA Prescription Food 98

Pharmacy Times

MAY 23, 2023

The FDA’s final decision is expected by a Prescription Drug User Fee Act goal date in August 2023.

Prescription 49

Prescription FDA 49

Pharmacy Times

DECEMBER 21, 2022

The FDA granted Priority Review to both applications and set a Prescription Drug User Fee Act goal date for each application of April 21, 2023.

FDA 49

FDA Prescription 49

Pharmaceutical Technology

MAY 25, 2023

The US Food and Drug Administration has set 23 September 2023 as the prescription drug user fee action date for ATI-1501.

Food and Drug Administration 105

Food and Drug Administration Prescription Food Medicine 105

Pharmaceutical Technology

JUNE 12, 2023

Patients with erectile dysfunction (ED) will now be able to access a topical treatment without the need for a prescription after the US Food and Drug Administration (FDA) greenlit Futura Medical’s Eroxon. Futura says it plans to continue launches throughout 2023. ED affects approximately 18% of men in the US.

Food and Drug Administration 52

Food and Drug Administration FDA Prescription Food 52

Clarivate

APRIL 18, 2024

Amazon’s big splash happened in February 2023 when it purchased the national primary-care practice One Medical for $3.9 RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52

Retail Healthcare Healthcare Physicians 52

Pharmaceutical Technology

MAY 2, 2023

The regulatory body has also granted priority review to the application and set 28 August 2023 as a target date for the prescription drug user fee act (PDUFA). The European Medicines Agency (EMA) has also validated the Type II variation application for Reblozyl.

Food and Drug Administration 98

Food and Drug Administration FDA Safety Prescription 98

Pharma Leaders

MARCH 26, 2023

have introduced the Affordable Insulin Now Act of 2023, which would cap out-of-pocket insulin costs at $35 a month for both insured and uninsured individuals. Raphael Warnock (D-Ga.) and John Kennedy (R-La.) This bill is a follow-up to a bill Sen. The bill was signed into law in August 2022.

Insurance 52

Insurance Prescription 52

Pharmaceutical Technology

MAY 16, 2023

In January 2023, the US Food and Drug Administration (FDA) approved lecanemab under the accelerated approval pathway to treat AD. The regulator has also accepted Eisai’s supplemental biologics licence application (sBLA) for lecanemab and granted priority review, with 6 July 2023 as the prescription drug user fee act (PDUFA) action date.

Food and Drug Administration 52

Food and Drug Administration Prescription Food FDA 52

Contrarian Sales Techniques

FEBRUARY 24, 2023

The company also offers online prescriptions and delivery services for medications. MyDoc - MyDoc is a telemedicine company that offers virtual consultation services with certified doctors, as well as online prescription services and medication delivery. The company also provides corporate healthcare solutions for businesses.

Medical sales reps 52

Medical sales reps Medical sales Medical Sales 52

Pharmaceutical Technology

MAY 26, 2023

The FDA has now assigned a prescription drug user fee act action date of 23 November 2023 for the NDA.

Food and Drug Administration 105

Food and Drug Administration FDA Prescription Food 105